Skip to main content

Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects

Abstract

Reportedly, the responsiveness of somatotrope cells to GHRH is reduced in elderly humans but it is totally restored by arginine (ARG) which likely acts by inhibiting hypothalamic release of somatostatin. As this effect was observed after infusion of high doses of the amino acid, in this study, we compared the effect of iv administration of 30,10 and 5 g ARG(group A,B and C, respectively) as well as oral administration of 8 g ARG(group D) on the GH response to 1 μg/kg iv GHRH in 27 healthy elderly subjects (11 M and 16 F, age 70–86 yr, BMI 21–25 kg/m2). In group A (n=7) 30 g iv ARG strikingly enhanced the GHRH-induced GH rise (peak, mean±SE: 41.5±4.4 vs 11.7±5.3 μg/L, p<0.05). Similarly, in group B (n=6) and D (n=7) 10 g iv and 8 g oral ARG enhanced the GH response to GHRH (20.9±4.7 vs 8.3±2.8 μg/L, p<0.03 and 31.0±5.3 vs 11.4±3.4 μg/L, p<0.03, respectively). In contrast, in group C (n=7) 5 g iv ARG failed to modify the GHRH-induced GH rise (6.0±1.6 vs 3.5±0.9 μg/L). The GH responses to GHRH alone did not significantly differ amongst groups; the GH responses to GHRH and ARG were not significantly different among groups A, B and D and were greater than the GH response in group C. These results show that the GH response to GHRH in elderly subjects is enhanced even by low iv doses of arginine and by the orally administered amino acid, the lowest effective dose being 8 g. Moreover, they imply that the combined administration of GHRH and arginine may be a useful approach to restore the impaired function of the GH-IGF axis in aging.

This is a preview of subscription content, access via your institution.

References

  1. Rudman D., Kutner M.H., Rogers M., Lubin M.F., Fleming G.A., Bain R.P. Impaired growth hormone secretion in the adult population. J.Clin. Invest. 67: 1361, 1981.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  2. Zadik Z., Chalew S.A., McCarter R.J., Meistes M., Kowarski A. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab. 60: 513, 1985.

    CAS  PubMed  Article  Google Scholar 

  3. Rudman D., Feller A.G., Nagraj H.S. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323: 1, 1990.

    CAS  PubMed  Article  Google Scholar 

  4. Ghigo E., Goffi S., Nicolosi M., Arvat E., Procopio M., Bellone J., Mazza E., Camanni F. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J. Clin. Endocrinol. Metab. 71: 1481, 1990.

    CAS  PubMed  Article  Google Scholar 

  5. Ghigo E., Arvat E., Goffi S., Bellone J., Valente F., Procopio M., Ghigo M.C., Camanni F. Repetitive GHRH and arginine administration to explore the maximal secretory capacity of somatotroph cells during lifespan. Clin. Exp. Endocrinol. 10: 191, 1991.

    Google Scholar 

  6. Sonntag W.E., Forman L.J., Miki N. Effects of CNS active drugs and somatostatin antiserum on growth hormone release in young and old male rats. Neuroendocrinology 33: 73, 1981.

    PubMed  Article  Google Scholar 

  7. Morimoto N., Kawakami F., Makino S., Chihara K., Hasegawa M., Ibata Y. Age-related changes in growth hormone releasing factor and somatostatin in the rat hypothalamus. Neuroendocrinology 47: 459, 1988.

    CAS  PubMed  Article  Google Scholar 

  8. De Gennaro Colonna V., Zoli M., Cocchi D., Maggi A., Marrama P., Agnati L.F., Muller E.E. Reduced growth hormone releasing factor (GHRH)-like immunoreactivity and GHRH gene expression in hypothalamus of aged rats. Peptides 10: 705, 1989.

    Article  Google Scholar 

  9. Ge F., Tsagarakis S., Rees L.H., Besser G.M., Grossman A. Relationship between growth hormone-releasing hormone and somatostatin in the rat: effects of age and sex on content and in vitro release from hypothalamic expiants. J. Endocrinol. 123: 53, 1989.

    CAS  PubMed  Article  Google Scholar 

  10. Locatelli V., Cella S.G., Cermenati P., Panzeri G., Sellan R., Muller E.E. Defective growth hormone (GH) secretion in aging mammals: contribution of central and peripheral inhibitory influences and of GH-releasing hormone. In: Valenti G. (Ed.), Psychoneuroendocrinology of aging: basic and clinical aspects. Fidia Research Series, vol 16, Liviana Press, Padova, 1989, p. 67.

    Google Scholar 

  11. Parker M.L., Hammonds J.M., Daughaday W.H. The arginine provocative test: an aid in the diagnosis of hyposoinatotropism. J. Clin. Endocrinol. Metab. 27: 1129, 1967.

    CAS  PubMed  Article  Google Scholar 

  12. Alba Roth J., Albrecht A., Muller O., Schopol J., Von Werden K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 67: 1186, 1988.

    CAS  PubMed  Article  Google Scholar 

  13. Page M.D., Dieguez C., Valcavi R., Edwards C., Hak R., Scanion M.F. Growth hormone (GH) responses to arginine and I-dopa alone and after GHRH pretreatment. Clin. Endocrinol. (Oxf.) 28: 551, 1988.

    CAS  Article  Google Scholar 

  14. Keljman M. Age-related alterations of the growth hormone/insulin-like growth factor I axis. J.A.G.S. 39: 295, 1991.

    Google Scholar 

  15. Ghigo E., Arvat E., Valente F., Nicolosi M., Boffano G.M., Procopio M., Bellone J., Maccaro M., Mazza E., Camanni F. Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. Neuroendocrinology 54: 291, 1991.

    CAS  PubMed  Article  Google Scholar 

  16. Ghigo E., Miola C, Aimaretti G., Valente F., Procopio M., Arvat E., Yin-Zhang W., Camanni F. Arginine abolishes the inhibitory effect of glucose on the growth hormone response to GHRH in man. Metabolism 41: 1000, 1992.

    CAS  PubMed  Article  Google Scholar 

  17. Merimee I.J., Rabinowitz M.D., Fineberg S.E. Arginine -initiated release of human growth hormone. N. Engl. J. Med. 26: 1434, 1969.

    Article  Google Scholar 

  18. Goffi S., Ghigo E., Arvat E., Bellone J., Imperiale E., Procopio M., Dammacco F., Camanni F. Sex- and age-related difference in the potentiating effect of arginine on the GHRH-induced GH rise in humans. J. Endocrinol. Invest 15 (Suppl.4): 98, 1992.

    Google Scholar 

  19. Ghigo E., Goffi S., Arvat E., Imperiale E., Boffano G.M., Valetto M.R., Mazza E., Santi I., Magliona A., Boghen M.F., Boccuzzi G., Camanni F. A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging. J. Endocrinol. Invest. 15: 665, 1992.

    CAS  PubMed  Article  Google Scholar 

  20. Rowe W.J., Kahn R.L. Human aging: usual and successful. Science 237: 143, 1987.

    CAS  PubMed  Article  Google Scholar 

  21. Corpas E., Harman S.M., Pineyro M.A., Roberson R., Blackman M.R. Growth hormone (GH)-releasing hormone (1–29) twice daily reverses the decreased GH and insulinlike growth factor I levels in old men. J. Clin. Endocrinol. Metab. 75: 530, 1992.

    CAS  PubMed  Google Scholar 

  22. Bowers C.Y., Alster D.K., Frentz J.M. The GH-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J. Clin. Endocrinol. Metab. 74: 292, 1992.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ghigo, E., Ceda, G.P., Valcavi, R. et al. Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects. J Endocrinol Invest 17, 113–117 (1994). https://doi.org/10.1007/BF03347695

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347695

Key-words

  • Aging
  • GH
  • GHRH
  • arginine